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Background
CD4+ T cells are critical for effective immune responses
against HIV, but these cells are targeted by the virus. Here
we evaluated the capacity of HIV-specific CD4+ T cells to
produce IFN-y and -chemokines and how they were
affected by HIV infection.
Materials and methods
HIV gp120-specific CD4+ T cell lines (PS01 and PS02)
were generated from PBMCs of HIV+ patients. Intracellu-
lar staining and ELISA were used to detect IFN-y, -chem-
okines, and virus infection.
Results
The CD4+ T cells produced IFN-y and MIP-1a in response
to gp120. Also detected were RANTES and MIP-1a, but not
MDC (CCL22). The b-chemokines displayed potent
inhibitory activities against R5-tropic HIV-1. After the cells
were exposed to BX08 (an R5 subtype B HIV-1 primary
isolate), the capacity of these cells to produce IFN-y and
MIP-1a in response to gp120 was initially comparable
with that of the unexposed control. But after 3–4 days of
infection, the numbers of cells capable of producing IFN-
y and MIP-1a decreased significantly, while the percentage
of infected cells reached >80%.
Conclusion
HIV-specific CD4+ T cells are susceptible to HIV. HIV
reduces the capacity of the cells to produce IFN-y and b-
chemokines. On-going efforts to enhance HIV-specific
CD4+ T cell resistance against the virus will be presented.
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